Amy,
If your PI is working with saccharomyces cerevisiae, look in Appendix C-III and Appendix
E-II.  The long list of agents classified by "risk group" is in Appendix B.  Here's a
link to the guidelines, if you need it:
http://www4.od.nih.gov/oba/rac/guidelines/guidelines.html
Pamela

Amy Hibbard wrote:

> I have a PI who is applying for a grant in which he'll be working with yeast
> DNA.  Because he is technically using recombinant DNA, though a
> non-hazardous fungus, we are required to show that the proposal has been
> reviewed by our Institutional Biosafety Committee.  Does anyone know where
> in the NIH Guidelines for Research Involving Recombinant DNA Molecules it
> deals with these non-hazardous, non-animal recombinant DNA molecules?  Or
> has anyone had a similar experience that would shed some light on our
> responsibilities in this case?
> Thanks,
> Amy Hibbard
>
> "All power corrupts, but we need the electricity."
>
> Amy Hibbard
> Grants Administrator
> Keck Graduate Institute of Applied Life Sciences
> 535 Watson Drive, Claremont, CA 91711
> T: (909) 607-9313 / 607-7855
> F: (909) 607-8086
> xxxxxx@kgi.edu
> www.kgi.edu

--
 Pamela Napier, Information Coordinator
 Office of Sponsored Programs
 Western Kentucky University
 1 Big Red Way, Bowling Green, KY  42101-3576
 Phone:  270.745.5328
 Fax:  270.745.4211
 E-mail:  xxxxxx@wku.edu  mailto:xxxxxx@wku.edu
 http://www.wku.edu/Dept/Support/SponsPrg/grants/

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================